Clinical trials recruiting for Renal Cell Carcinoma (RCC)
10
Recruiting trials
30
US states with sites
16
Countries
0%
Accept healthy volunteers
Phase breakdown
Drugs and treatments being studied
Where trials are recruiting (top US states)
| State | Recruiting trials |
|---|---|
| Florida | 4 |
| Arizona | 3 |
| New York | 3 |
| Ohio | 3 |
| Illinois | 2 |
| Massachusetts | 2 |
| Minnesota | 2 |
| New Jersey | 2 |
| Tennessee | 2 |
| Texas | 2 |
| Virginia | 2 |
| Alabama | 1 |
Top cities
Cleveland, Ohio 3New York, New York 3Boston, Massachusetts 2Chicago, Illinois 2Hackensack, New Jersey 2Jacksonville, Florida 2Nashville, Tennessee 2Rochester, Minnesota 2Scottsdale, Arizona 2Atlanta, Georgia 1
Self-screener
Recruiting trials
- A Phase 1 and 2 Study of VMD-102 in Hepatocellular Carcinoma and Other Solid Tumors
- A Phase I Study of SIM0505 in Participants With Advanced Solid Tumors
- A Study of GI-108, an Anti-CD73-IgG4 Fc-IL-2v Bispecific Fusion Protein, as Monotherapy in Patients With Advanced or Metastatic Solid Tumors
- A Study to Evaluate the Safety and Therapeutic Activity of GI-102 As a Single Agent and in Combination with Conventional Anti-cancer Drugs, Pembrolizumab or Trastuzumab Deruxtecan(T-DXd) in Patients with Advanced Solid Tumors (KEYNOTE-G08)
- CD70-Targeted CAR-T Therapy in CD70-Positive Advanced Solid Tumors
- Phase 2 Study for the Patient, Who Has Diagnosed With Small Cell Lung Cancer (SCLC) or Non Small Cell Lung Cancer (NSCLC) or Renal Cell Carcinoma (RCC) and Finished the First Line Stand Treatment , Need More Treatment
- Registry of Minimally Invasive Cancer Treatment Using Spectral Angio-CT Image Guidance
- Sapu003 in Advanced mTOR-sensitive Solid Tumors
- Study of Zanzalintinib in Combination With Immuno-Oncology or Other Agents in Participants With Solid Tumors
- Study to Evaluate LB-LR1109, Administered Alone for the Treatment of Solid Tumor and in Combination With Atezolizumab for the Treatment of NSCLC
Related conditions
Trials recruiting for Renal Cell Carcinoma (RCC) often also study these conditions. Each links to its own recruiting-trial list.
Lung cancer 2180Hepatocellular Carcinoma (HCC) 15Non-small cell lung cancer 507Melanoma 487Colorectal cancer 50Metastatic Solid Tumor 22Head and Neck Squamous Cell Carcinoma (HNSCC) 11Colorectal cancer 1359Breast cancer 2239Urothelial Carcinoma (UC) 5
Common questions
Are these trials free to join?
Study-related care in a clinical trial is usually provided at no cost to participants, and some trials reimburse travel. Costs vary by study - the trial team will explain what is and is not covered. Confirm this directly with them.
How do I know if I am eligible for Renal Cell Carcinoma (RCC) trials?
Each trial lists inclusion and exclusion criteria. The screener above checks stated age and sex only. The full eligibility (your medical history, current medications, test results) is assessed by the study team. Open any trial to read its criteria, then contact the site.
Is this list complete?
No. For the full list, search ClinicalTrials.gov.